SNDL completes Parallel asset acquisition for US medical cannabis ops
SNDL Inc. has finalized the acquisition of Parallel assets, securing indirect majority stakes in U.S. medical cannabis operations across Florida, Texas, and Massachusetts. The deal eliminates US$842 million in debt and adds 56 retail stores with US$150 million in annualized revenue to SNDL's portfolio. While immediate financial impact is limited to a discounted loan acquisition, the move sets the stage for future consolidation of direct holdings, subject to regulatory approvals.
*this image is generated using AI for illustrative purposes only.
SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) completed the acquisition of certain assets from Surterra Holdings, Inc. and its affiliates, collectively known as Parallel, on July 27, 2026. The transaction, executed through a strict foreclosure agreement, grants SNDL indirect majority economic exposure to U.S. medical cannabis operations in Florida, Texas, and Massachusetts. This move positions SNDL to potentially become one of the first Nasdaq-listed companies with direct, consolidated exposure to U.S. medical cannabis operations, subject to regulatory and accounting approvals. The acquisition substantially reduces the legacy debt burden of the acquired business, extinguishing approximately US$842 million of debt obligations.
The Parallel Transaction was structured through CDXX TransCo, LLC ("TransactionCo"), involving a consensual secured creditor foreclosure of specified equity interests and assets. SNDL, through its Sunstream Bancorp Inc. ("Sunstream") joint venture, now holds indirect economic exposure equivalent to ownership of 66.7% of TransactionCo’s equity and 69.4% of its debt. The company expects to convert this indirect exposure into direct, consolidated holdings in the coming months, pending legal, regulatory, accounting, and Nasdaq requirements. Any adult-use or recreational exposure, including in Massachusetts, will remain deconsolidated unless Nasdaq, applicable law, and accounting standards permit otherwise.
Zach George, Chief Executive Officer of SNDL, stated that closing the transaction marks a defining milestone in the company’s strategy to become a leading vertically integrated North American cannabis company. He noted that SNDL now supports a 249-store cannabis retail network, the largest in the world by store count. George emphasized that operating discipline and retail expertise from Canada’s competitive market will aid expansion in key U.S. medical markets like Florida, Massachusetts, and Texas.
Operating Platform Details
The acquired assets include 56 retail locations and three cultivation and manufacturing facilities across three states, generating annualized revenue of approximately US$150 million. The footprint is distributed as follows:
| State | Retail Locations | Brand | Cultivation/Production Facility |
|---|---|---|---|
| Florida | 43 dispensaries | Surterra Wellness | 1 facility (~175,000 sq ft) |
| Texas | 10 retail/pickup locations | Goodblend | 1 facility |
| Massachusetts | 3 dispensaries | New England Treatment Access (NETA) | 1 facility (~19,600 sq ft) |
Goodblend operates as one of only three active licensed operators in Texas, serving a population of approximately 31.7 million residents. This population is roughly 35% larger than Florida’s and more than three-quarters the size of Canada’s.
Financial Reporting and Background
The closing of the Parallel Transaction does not have an immediate impact on SNDL’s financial reporting, except for the acquisition of a US$29.75 million principal loan position from PE Fund LP at a 25% discount to par value. This investment continues to be accounted for using the equity method under International Financial Reporting Standards based on SNDL’s indirect economic exposure. Consolidation of TransactionCo’s medical business will occur once SNDL converts its indirect exposure into direct majority equity and debt exposure resulting in operational control.
Talladega LP ("Talladega"), wholly owned by Sunstream affiliates, initially provided Parallel with a US$150 million secured loan on May 7, 2021. Following defaults on this loan and senior secured notes, Talladega and senior noteholders provided additional financing to preserve enterprise value. After an unsuccessful marketing process for third-party transactions, the parties pursued the strict foreclosure transaction completed today. Weil, Gotshal & Manges LLP acted as legal counsel, while Moelis & Company served as exclusive financial advisor to Sunstream and Talladega.
What specific regulatory or accounting hurdles must SNDL clear to consolidate Parallel's operations, and what is the estimated timeline for achieving direct majority equity control?
How will the integration of Surterra Wellness and Goodblend impact SNDL's EBITDA margins given the differing competitive landscapes in Florida's mature market versus Texas's nascent medical sector?
With approximately US$842 million in debt extinguished, how does SNDL plan to leverage the improved balance sheet to fund further expansion or reduce its own corporate leverage?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
